ARTICLE. Risk of Mental Retardation Among Children Born With Birth Defects
|
|
- Melina Ramsey
- 6 years ago
- Views:
Transcription
1 ARTICLE Risk of Mental Retardation Among Children Born With Birth Defects Laura L. Jelliffe-Pawlowski, PhD; Gary M. Shaw, DrPH; Verne Nelson, MS; John A. Harris, MD, MPH Background: A paucity of epidemiologic research exists concerning the co-occurrence of birth defects and mental retardation (MR). Study of this co-occurrence may yield important clues about the causes of both. Objective: To examine the co-occurrence of birth defects and MR, taking into consideration the type of birth defect, level of MR, co-occurrence of MR with other developmental disabilities, and individual and maternal factors. Design: A retrospective cohort study of infants born in the California Central Valley with and without a structural birth defect by 1 year of age, and with or without MR by 7 to 9 years of age. Setting and Participants: One-year survivors (N=119556) born in nonmilitary hospitals in 8 California counties between January 1, 1992, and December 31, 1993, for whom information about birth defects was recorded within the first year of life. Main Outcome Measure: Diagnosis of MR by age 7 years considered as being mild or severe and as occurring without other developmental disabilities (isolated MR) or as occurring with other developmental disabilities, including cerebral palsy, epilepsy, or a pervasive developmental disorder. Results: Children with birth defects were nearly 27 times more likely to have MR by 7 years of age compared with children without a diagnosed birth defect regardless of type of defect (prevalence ratio, 26.8; 95% confidence interval, ). Among those with birth defects, children with Down syndrome (prevalence ratio, 211.7; 95% confidence interval, ) and children with sex chromosomal defects (prevalence ratio, 57.4; 95% confidence interval, ) were at the highest risk for MR. Children with nonchromosomal defects, including central nervous system defects and all types of organ and system defects, were at substantially increased risk for all levels of MR. Risks of MR among children with Down syndrome and nonchromosomal defects were not substantially altered when adjusted for individual and maternal factors. Conclusions: Children with chromosomal and other structural birth defects are at a substantially increased risk for having MR by 7 years of age compared with children born without a birth defect. Children with birth defects are at an especially increased risk for having severe MR and MR occurring independently of other developmental disabilities. Arch Pediatr Adolesc Med. 2003;157: From the March of Dimes Birth Defects Foundation, California Birth Defects Monitoring Program, Oakland. Dr Jelliffe-Pawlowski is now affiliated with the Childhood Lead Poisoning Prevention Branch, California Department of Health Services, Oakland. MANY EPIDEMIOLOGIC studies 1-6 have investigated structural birth defects and mental retardation (MR) separately. However, few studies have investigated this co-occurrence. Although data suggest that children with structural defects are at increased risk for having MR in childhood, 7,8 limited information is available with respect to defect-specific and MR severity specific risks. Kirby and colleagues 8 found that nearly 70% of children with neural tube defects and nearly 46% of children with chromosomal defects had a developmental disability (DD) (including MR) by 4 years of age. Decoufle and colleagues 7 found an 8-fold risk of MR among children who were aged between 3 and 10 who were born with 1 or more birth defects, compared with children born without birth defects. Therefore, studies 7,8 have focused on birth defects and developmental disabilities in general but have not examined the association between specific birth defects and specific levels of MR. Co-occurrence may indicate an alternative cause compared with the occurrence of these conditions in isolation. By investigating co-occurrence, important clues about the cause of both conditions, particularly about the timing of potential insults, may be revealed. We investigated the relationship between specific birth defects and sever- 545
2 ity of MR in a cohort of California-born children. We determined whether the risk of MR differed by type of chromosomal or structural birth defect and explored whether severity of MR or the occurrence of MR in combination with other developmental disabilities differed by type of birth defect. Several individual and maternal factors were examined to determine effects on observed risks. METHODS The Institutional Review Board of the California Department of Health Services approved the protocol for this study. SUBJECTS AND SOURCES All infants born in nonmilitary hospitals from 8 California Central Valley counties (Fresno, Kern, Kings, Madera, Merced, San Joaquin, Stanislaus, and Tulare) in 1992 and 1993 who survived to 1 year of age were included (N=119556). Information about survival, sex, plurality, gestational age, birth weight, maternal age, maternal race/ethnicity, parity, maternal birthplace, and maternal education was obtained from birth certificate and infant mortality files. Information about birth defects was derived from the California Birth Defects Monitoring Program. 9,10 This populationbased active surveillance system collects diagnostic information from multiple sources of medical records on all stillborn and liveborn infants with structural birth defects diagnosed within 1 year of delivery in a subset of California counties, including the 8 counties targeted for this study. 10 Ascertainment is estimated to be 97% complete. 9,10 Of the infants surviving to 1 year in the specified birth counties and nonmilitary hospitals, 2337 were diagnosed as having 1 or more birth defects. Information about MR was obtained from the California Department of Developmental Services, Sacramento. In California, individuals with developmental disabilities (defined as MR, cerebral palsy, epilepsy, autism, or other condition closely related to MR 11 ) are eligible to receive services from birth until death from this department via a system of independently operated regional centers across the state. A listing of all children born in 1992 and 1993 who were receiving services in March 2001 for a DD was obtained (n=9134). Records for these children were linked to birth certificate and infant mortality files by place of birth (when present) and by child, maternal, and paternal identifiers (including date of birth, first name, middle name, last name, and mother s maiden name). All matches were verified via record review. Using this method, 895 children receiving services in 2001 were identified as born at nonmilitary hospitals in the study counties between January 1, 1992, and December 31, These children were further linked to California Birth Defects Monitoring Program files to identify those with birth defects. Service delivery charts for 893 of the 895 children were found and reviewed. Among these, 635 had MR based on American Association on Mental Deficiency (AAMD) guidelines. 12 Twenty-two had normal intellectual functioning before severe head trauma, near drowning, or stroke and were excluded based on our objective to investigate potentially unknown causes. We categorized the remaining 613 individuals into 2 severity groups consistent with AAMD criteria using IQ or adaptive functioning. The 2 groups were mild MR and severe MR, the latter corresponding to the AAMD criteria for moderate, severe, or profound MR. Included in the mild MR group were 259 children tested as having an IQ between 50 and 70 on their last psychometric testing and an additional 59 children who did not have standardized testing within 3 years but were consistent with AAMD adaptive functioning criteria for mild MR and had a diagnosis of mild MR from a licensed psychologist who had conducted an in-person evaluation of the child. Included in the severe MR group were 213 children who tested as having an IQ less than 50 on their last psychometric testing and an additional 72 children who did not have standardized testing within the past 3 years but were consistent with adaptive functioning criteria for severe MR and had a diagnosis of moderate MR, severe MR, or profound MR from a licensed psychologist who had conducted an in-person evaluation. Ten children who were found to have MR based on reported adaptive functioning did not have a specific diagnosis or enough information present to determine the level of MR and were excluded from all analyses. Therefore, the analytic database used included 318 children with mild MR and 285 children with severe MR. Information about the presence of other developmental disabilities was collected. Children with MR were coded as having (1) cerebral palsy if there was a clear diagnosis made by a physician; (2) epilepsy if there was a clear diagnosis made by a physician; or (3) pervasive developmental disorder (PDD) if diagnosed with autistic disorder, Rett disorder, childhood disintegrative disorder, Asperger disorder, or unspecified PDD. Diagnosis of a PDD was only considered if made by a psychologist or physician using standard criteria. 13 Among children with mild MR, 109 (34.3%) had cerebral palsy (n=30), epilepsy (n=43), or a PDD (n=49) and were therefore classified as having mild MR with another DD (diagnoses not mutually exclusive). The remaining 209 children with mild MR and no other DD were classified as having isolated MR. Among children with severe MR, 173 (60.7%) had cerebral palsy (n=83), epilepsy (n=117), or PDD (n=50) and were classified as having severe MR co-occurring with another DD (diagnoses not mutually exclusive). The 112 remaining children with severe MR and no other diagnosed DD were classified as having isolated MR. STATISTICAL ANALYSIS Prevalences of MR groupings were estimated among infants with (n=2337) or without (n=117219) birth defects. Prevalences of MR groupings were also estimated among infants grouped into 4 mutually exclusive birth defect categories, including Down syndrome (n=155), other autosomal abnormality (n=36), sex chromosomal abnormality (n=26), unspecified chromosomal abnormality (n=2), and nonchromosomal abnormality (n=2118). Mental retardation prevalences were further estimated for specific birth defects among children with nonchromosomal defects. Prevalences of MR (by subgrouping) per 1000 children with birth defects (overall and by subtype) were estimated. The prevalence of MR among children with a specified birth defect was compared with the prevalence of MR among children without any major birth defect. The ratios of these prevalences, along with 95% confidence intervals (CIs), were computed using Poisson regression techniques. The potential contribution of individual and maternal factors was estimated by adjustment using Poisson regression models. All regression modeling was done using Statistical Analysis Software, version Individual factors studied included sex, race/ethnicity (white, Hispanic, black, Asian, or other, which included Native Americans, Pacific Islanders, and Alaskan Natives), plurality (singleton or multiple), gestational age ( 37 or 37 weeks), and birth weight ( 2500 or 2500 g). Maternal factors studied included age at delivery ( 20, 20-24, 25-29, 30-34, or 35 years), years of education ( 12, 12, 13-16, or 17), birthplace (United States, Mexico, or other), and parity (0 or 1). 546
3 Table 1. Prevalence of Mild Mental Retardation (MR) Among 1-Year Survivors Born in the California Central Valley in 1992 and 1993 Without Birth Defects vs Prevalence of Mild MR Among Children With Birth Defects* Isolated Mild MR Mild MR and Other Disability No. No. per 1000 Ratio (95% CI) No. No. per 1000 Ratio (95% CI) No birth defect (n = ) Referent Referent Any birth defect (n = 2337) ( ) ( ) Down syndrome (n = 155) ( ) Other autosomal abnormality (n = 36) ( ) ( ) Sex chromosomal abnormality (n = 26) ( ) Nonchromosomal abnormality (n = 2118) ( ) ( ) *Number per 1000 is by birth defect grouping (survivors to 1 year, nonmilitary births). Ratio is prevalence of mild MR among individuals with the specified birth defect divided by the prevalence of mild MR among individuals without a major birth defect. Prevalence is by birth defect grouping and by co-occurrence with other development disabilities including cerebral palsy, epilepsy, or a pervasive developmental disorder. RESULTS The study cohort included similar numbers of males and females (51% and 49%, respectively) and was predominantly white or Hispanic (38% and 47%, respectively). Most children were born to women with 12 (31%) or fewer (44%) years of education, who were born in the United States (62%). Overall, MR occurred in 5 (mild MR, 2.6; severe MR, 2.4) per 1000 births. Birth defects occurred in 19.5 (Down syndrome, 1.3; other autosomal defects, 0.3; sex chromosomal defects, 0.2; and nonchromosomal defects, 17.7) per 1000 births. Children with birth defects were observed to be at nearly a 27-fold risk of having MR diagnosed by 7 years of age compared with children without birth defects (prevalence ratio [PR], 26.8; 95% CI, ). Children with Down syndrome were at a more than 200-fold risk of MR (PR, 211.7; 95% CI, ), children with sex chromosomal defects were at nearly a 60-fold increased risk (PR, 57.4; 95% CI, ), and children with nonchromosomal defects were at more than an 11-fold increased risk (PR, 11.1; 95% CI, ) of having MR compared with children without birth defects. The risk of MR among children with Down syndrome and nonchromosomal defects did not decrease substantially when adjusted for individual and maternal covariates (PR, 178.4; 95% CI, ; and PR, 8.9; 95% CI, ; respectively). A further evaluation of these large risks by more detailed MR subgroupings revealed that the largest MR risks among children with birth defects tended to be for severe MR and isolated MR (Table 1 and Table 2). Furthermore, analyses of MR risks in children with specific nonchromosomal birth defects revealed that infants with all types of organ- and system-level defects at birth, including those not associated with the central nervous system, were at substantially increased risks for all levels of MR (Table 3 and Table 4). These MR risks tended to be the largest among infants born with central nervous system and heart defects. COMMENT Our findings indicate that being born with a structural birth defect, including birth defects not involving the central nervous system, elevates an infant s risk of developing mild or severe MR by 7 to 9 years of age by as much as several hundred fold. Our findings extend the knowledge base concerning MR risks among children with birth defects. Our findings are consistent with previous investigations that found children with birth defects at greater risk for being diagnosed as having developmental disabilities, including MR, in early childhood 7,8 and for being diagnosed as having isolated MR and severe MR. 7,8 However, we found larger risks than other investigators. Specifically, we found that children with a birth defect were at a 27-fold increased risk for MR, compared with an 8-fold increased risk observed by Decoufle and colleagues. 7 Our larger observed risks may be due to differences in study design, including differences in population and case eligibility criteria. For example, most children in our study cohort were white or Hispanic, whereas most children in the study by Decoufle et al 7 were white or black. We used adaptive evaluations of intellectual functioning, in addition to using IQ, when diagnosing and categorizing children with MR. This inclusion, while reflective of AAMD, 12 American Association on Mental Retardation, 15 and American Psychological Association 13 guidelines, represents a departure from the methods used by Decoufle and colleagues, who used IQ score exclusively. Elevated risks of MR among children with birth defects indicate that the causes of MR may differ between those children who are born with birth defects compared with those born without birth defects. Such observations specifically provide evidence to suggest a prenatal cause for MR when there is co-occurrence. Taken together with the hundreds of studies that have identified specific syndromes that include MR and 1 or more birth defects as phenotypic components (eg, Mowat- Wilson, 16 Hennekam, 17 and Jancar 18 syndromes), elevated risks suggest that MR and birth defects may be pathogenetically related. This relationship may be causal (eg, a specific birth defect causes MR), temporal (eg, a deleterious event or teratogen caused the birth defect and MR), or genetic (eg, a gene or genes caused the birth defect and MR) or may be characterized by multiple causal pathways and mechanisms. This study represents a rigorous first step toward investigating the potential association between specific birth defects and the risk of MR by severity and co- 547
4 Table 2. Prevalence of Severe Mental Retardation (MR) Among Children Without an Identified Birth Defect vs Prevalence of Severe MR Among Children With Birth Defects* Isolated Severe MR Severe MR and Other Disability No. No. per 1000 Ratio (95% CI) No. No. per 1000 Ratio (95% CI) No birth defect (n = ) Referent Referent Any birth defect (n = 2337) ( ) ( ) Down syndrome (n = 155) ( ) ( ) Other autosomal abnormality (n = 36) ( ) ( ) Sex chromosomal abnormality (n = 26) ( ) ( ) Nonchromosomal abnormality (n = 2118) ( ) ( ) *Number per 1000 is by birth defect grouping (survivors to 1 year, nonmilitary births). Ratio is prevalence of severe MR among individuals with the specified birth defect divided by the prevalence of mild MR among individuals without a major birth defect. Prevalence is by birth defect grouping and by co-occurrence with other developmental disabilities including cerebral palsy, epilepsy, or a pervasive developmental disorder. Table 3. Prevalence of Mild Mental Retardation (MR) Among Children With Specific Types of Nonchromosomal Birth Defects vs Prevalence of Mild MR Among Children Without Any Birth Defects* Isolated Mild MR Mild MR and Other Disability No. per 1000 Ratio (95% CI) No. per 1000 Ratio (95% CI) No birth defect (n = ) 1.1 Referent 0.8 Referent Spina bifida (n = 29) ( ) Other nervous system defect (n = 232) ( ) ( ) Other structural defects Eye (n = 204) ( ) ( ) Ear, face, and neck (n = 170) ( ) Bulbus cordis or cardiac septal closure (n = 163) ( ) ( ) Other cardiac (n = 56) ( ) ( ) Circulatory system (n = 29) ( ) ( ) Respiratory system (n = 45) ( ) Cleft palate and cleft lip (n = 105) ( ) ( ) Other upper alimentary tract (n = 203) ( ) ( ) Other digestive system (n = 98) ( ) Genital organs (n = 244) ( ) Urinary system (n = 112) Musculoskeletal (n = 85) ( ) ( ) Limbs (n = 153) ( ) Other musculoskeletal (n = 90) ( ) ( ) Integument (n = 87) ( ) ( ) Other and unspecified anomalies (n = 13) *Children with specific types of nonchromosomal birth defects excludes all children with Down syndrome or other identified chromosomal defects. Number per 1000 is by birth defect grouping (survivors to 1 year, nonmilitary births). Ratio is prevalence of severe MR among individuals with specific birth defect divided by the prevalence of severe MR among individuals without a major birth defect. Excludes children with nervous system defects, not mutually exclusive of other structural birth defects. occurrence with other neurodevelopmental disabilities. These data, however, have associated limitations. Complete ascertainment of children with MR is challenging in the United States. Although we took steps to maximize case finding of children with MR, there is the possibility that children with birth defects were more likely to be identified as having MR because they may have been more likely to be under greater medical scrutiny and therefore more likely to be receiving regional center services. Such a situation, if present, would likely have a greater effect on risk estimation associated with mild MR, owing to the fact that the prevalence of mild MR is lower than reported in some other studies, 3 whereas the prevalence of severe MR in this study is consistent with other studies, as is the prevalence of birth defects. 7,20 To minimize potential biased ascertainment, we focused on children who were diagnosed as having MR by age 7 to 9 and were actively receiving services in March 2001, when medical record review was initiated. By 1992, statewide programs were in place to identify newborns, infants, and children with MR, autism, cerebral palsy, and epilepsy. These regional center based programs work with hospitals, local agencies, and schools to identify and provide case management to children with these disorders. Focusing on children born in 1992 and 1993 ensured that children with MR or another DD had a minimum of 7 years to be identified by 1 or more professionals in this network, including at least 2 years in primary school. Focusing only on children who were actively receiving services meant that children were likely to have up-to-date 548
5 Table 4. Prevalence of Severe Mental Retardation (MR) Among Children With Specific Nonchromosomal Birth Defects vs Prevalence of Severe MR Among Children Without Any Birth Defects* Isolated Severe MR Severe MR and Other Disability No. per 1000 Ratio (95% CI) No. per 1000 Ratio (95% CI) No birth defect (n = ) 1.4 Referent 0.3 Referent Spina bifida (n = 29) ( ) Other nervous system defect (n = 232) ( ) ( ) Other structural defects Eye (n = 204) ( ) ( ) Ear, face, and neck (n = 170) ( ) ( ) Bulbus cordis or cardiac septal closure (n = 163) ( ) ( ) Other cardiac (n = 56) ( ) Circulatory system (n = 29) ( ) ( ) Respiratory system (n = 45) Cleft palate and cleft lip (n = 105) ( ) ( ) Other upper alimentary tract (n = 203) ( ) ( ) Other digestive system (n = 98) ( ) Genital organs (n = 244) ( ) ( ) Urinary system (n = 112) Musculoskeletal (n = 85) ( ) ( ) Limbs (n = 153) ( ) ( ) Other musculoskeletal (n = 90) ( ) ( ) Integument (n = 87) ( ) ( ) Other and unspecified anomalies (n = 13) ( ) ( ) *Children with specific nonchromosomal birth defects excludes all children with Down syndrome or other identified chromosomal defects. Number per 1000 is by birth defect grouping (survivors to 1 year, nonmilitary births). Ratio is the prevalence of severe MR among individuals with specific birth defect divided by the prevalence of severe MR among individuals without a major birth defect. Excludes children with nervous system defects, not mutually exclusive of other structural birth defects. What This Study Adds Although many epidemiologic studies have investigated structural birth defects and MR separately, few studies have investigated co-occurrence. Consequently, limited information is available regarding the risk of MR among children with specific birth defects. This study is unique in that it examined the association between specific birth defects and level of MR. Defect-specific risks are presented, which suggest that having a structural birth defect, including a defect not involving the central nervous system, substantially elevates an infant s risk for developing mental retardation by 7 to 9 years of age. These results suggest a need for ongoing developmental follow-up with infants and children born with 1 or more birth defects, including those with birth defects not typically thought to be associated with long-term cognitive difficulty. diagnostic information. We believe these strategies minimized underascertainment and maximized diagnostic accuracy. Still, the possibility remains that observed results were, at least in part, a reflection of ascertainment source. This approach also meant that children who had died, who had moved, or whose caregivers had refused services before March 2001 were not included. We observed some evidence for underascertainment. For example, we found that 71% of children with Down syndrome at birth had MR at age 7 to 9. This finding was lower than we expected and may be due to underascertainment of mild MR. It is also possible that some children with Down syndrome were functioning in the normal to borderline level of adaptive functioning and were not receiving services for MR. Our study was also limited in its evaluation of MR risk by specific birth defect phenotypes. Our sample size did not allow for risk estimations of finer definitions of birth defect phenotypes than those represented by the organ and system levels. This limitation did not diminish observed results but, rather, restricted our ability to make inferences about birth defect groupings that may have more homogeneous underlying pathogeneses. Despite these limitations, these data offer some insight into the complex causes of MR by narrowing the time frame of potential insult to the prenatal period in a large number of cases. They also argue for the need to consider children with and without structural birth defects as separate analytic groups for the purposes of disentangling the causes of MR. We suggest that future research, particularly in California, include other sources of case ascertainment, especially public and private schools and vital statistics death files. We also suggest that future research more thoroughly investigate the effect of considering adaptive functioning when diagnosing and subsequently studying MR, particularly in populations where MR is common. Accepted for publication January 16, This work was supported in part by the March of Dimes Birth Defects Foundation. We thank Kerri Ormerod for her assistance in all phases of the study and Rebecca Murray, MA, and Shelby Hyvonen, MA, for their assistance with clinical review. 549
6 Corresponding author and reprints: Laura L. Jelliffe- Pawlowski, PhD, Childhood Lead Poisoning Prevention Branch, California Department of Health Services, 1515 Clay St, Suite 1801, Oakland, CA ( REFERENCES 1. Williams LO, Decoufle P. Is maternal age a risk factor for mental retardation among children? Am J Epidemiol. 1999;149: Drews CD, Murphy CC, Yeargin-Allsopp M, Decoufle P. The relationship between idiopathic mental retardation and maternal smoking during pregnancy. Pediatrics. 1996;97: Boyle CA, Yeargin-Allsopp M, Doernberg NS, Holmgreen P, Murphy CC, Schendel DE. Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program, MMWR Morb Mortal Wkly Rep. 1996;45: Rantakallio P, von Wendt L. Risk factors for mental retardation. Arch Dis Child. 1985;60: Shaw GM, Lammer EL. Maternal periconceptional alcohol consumption and risk for orofacial clefts. J Pediatr. 1999;134: Wasserman CR, Shaw GM, O Malley CD, Tolarova MM, Lammer EJ. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology. 1996;53: Decoufle P, Boyle CA, Paulozzi LJ, Lary JM. Increased risk for developmental disabilities in children who have major birth defects: a population-based study. Pediatrics. 2001;108: Kirby RS, Brewster MA, Canino CU, Pavin M. Early childhood surveillance of developmental disorders by birth defects surveillance system: methods, prevalence comparisons, and mortality patterns. J Dev Behav Pediatr. 1995;16: Schulman J, Hahn JA. Quality control of birth defect registry data: a case study. Public Health Rep. 1993;108: Croen L, Shaw GM, Jensvold NG, Harris JA. Birth defects monitoring in California: a resource for epidemiologic research. Paediatr Perinat Epidemiol. 1991;5: Lanterman Act, California Welfare and Institutions Code 4512(a) (1969). 12. Classification in Mental Retardation. Washington, DC: American Association on Mental Deficiency; American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; Statistical Analysis Software (SAS). Version 8.0. Cary, NC: SAS Institute Inc; Mental Retardation: Definition, Classification, and Systems of Support. 10th ed. Washington, DC: American Association on Mental Retardation; Stromme P, Valvatne K. Mental retardation in Norway: prevalence and subclassification in a cohort of children born between 1980 and Acta Paediatr. 1998;87: Katusic SK, Colligan RC, Beard CM, et al. Mental retardation in a birth cohort, , Rochester, Minnesota. Am J Ment Retard. 1996;100: Steffenburg U, Hagberg G, Viggedal G, Kyllerman M. Active epilepsy in mentally retarded children, I: prevalence and additional neuro-impairments. Acta Paediatr. 1995;84: Hagberg G, Lewerth A, Olsson E, Westerberg B. Mild mental retardation in Gothenburg children born between : changes between two points of time. Uppsala J Med Sci Suppl. 1987;44: Schulman J, Edmonds LD, McClearn AB, Jensvold N, Shaw GM. Surveillance for and comparison of birth defect prevalences in two geographic areas United States, MMWR Morb Mortal Wkly Rep. 1993;42:
Parental age and autism: Population data from NJ
Parental age and autism: Population data from NJ Introduction While the cause of autism is not known, current research suggests that a combination of genetic and environmental factors may be involved.
More informationLessons from Population-Based Surveillance for ASD
Lessons from Population-Based Surveillance for ASD Marshalyn Yeargin-Allsopp, MD Medical Epidemiologist Developmental Disabilities Branch National Center on Birth Defects and Developmental Disabilities
More informationBIRTH DEFECTS IN MICHIGAN All Cases Reported and Processed by June 30, 2009
MICHIGAN DEPARTMENT OF COMMUNITY HEALTH Division for Vital Records and Health Statistics MICHIGAN BIRTH DEFECTS SURVEILLANCE REGISTRY BIRTH DEFECTS IN MICHIGAN All Cases Reported and Processed by June
More informationPrevalence of Autism Spectrum Disorders --- Autism and Developmental Disabilities Monitoring Network, United States, 2006
Surveillance Summaries December 18, 2009 / 58(SS10);1-20 Prevalence of Autism Spectrum Disorders --- Autism and Developmental Disabilities Monitoring Network, United States, 2006 Autism and Developmental
More informationREPORTING OF AUTISM IN THE NEW JERSEY SPECIAL CHILD HEALTH REGISTRY PRIOR TO THE IMPLEMENTATION OF THE 2007 MANDATORY REPORTING LAW
REPORTING OF AUTISM IN THE NEW JERSEY SPECIAL CHILD HEALTH REGISTRY PRIOR TO THE IMPLEMENTATION OF THE 2007 MANDATORY REPORTING LAW Nancy Scotto Rosato, PhD and Sandra Howell, PhD Special Child Health
More informationAutism Spectrum Disorder (ASD) Surveillance Year 2010 Findings
Arkansas Autism and Developmental Disabilities Monitoring (AR ADDM) Program Autism Spectrum Disorder (ASD) Surveillance Year 2010 Findings & Comparison with Arkansas 2002 Baseline Prevalence Study Eldon
More informationSupplementary Online Content
Supplementary Online Content Mølgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA. 2011;305(19):1996-2002. emethods. Birth defects and potential confounders
More informationARTICLE. Health Care Use by Children Diagnosed as Having Developmental Delay
ARTICLE Health Care Use by Children Diagnosed as Having Margaret M. Gallaher, MD, MPH; Dimitri A. Christakis, MD, MPH; Frederick A. Connell, MD, MPH Background: Although children with developmental delay
More informationAutism and Childhood MMR Vaccine Draft of Analysis Plan. September 5, 2001
Autism and Childhood MMR Vaccine Draft of Analysis Plan September 5, 2001 Introduction Autism is a serious life-long developmental disorder characterized by marked impairments in social interactions, and
More informationAutism and Childhood MMR Vaccine Draft of Analysis Plan September 5, 2001 Introduction Autism is a serious life-long developmental disorder characterized by marked impairments in social interactions, and
More informationRisk of congenital anomalies in children born after frozen embryo transfer with and without vitrification
Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Aila Tiitinen Professor, reproductive medicine Head of IVF unit Helsinki University The outline
More informationSyndromic X Linked Mental Retardation
Syndromic X Linked Mental Retardation Introduction : Dr. Yousef.A. Assaleh Dept. of Pediatric - faculty of medicine Zawia University Mental retardation is defined as incomplete or insufficient general
More informationPregnancy and Epilepsy
Pregnancy and Epilepsy Nowhere is the problem more evident or more complicated than in pregnancy. In the United States, epilepsy affects nearly one million women of childbearing potential. Alarm bells
More informationReanalysis of CDC Data on Autism Incidence and Time of First MMR Vaccination Brian S. Hooker, Ph.D., P.E.
Reanalysis of CDC Data on Autism Incidence and Time of First MMR Vaccination Brian S. Hooker, Ph.D., P.E. This study is a re-analysis of Centers for Disease Control and Prevention (CDC) data pertaining
More informationDisclosure. Outline PART 1: NUMBER AND CHARACTERISTICS OF CHILDREN WITH ASD
Autism Spectrum Disorder: Findings from CDC s Autism and Developmental Disabilities Monitoring Network I have nothing to disclose. Disclosure Marshalyn Yeargin-Allsopp, MD Medical Epidemiologist and Branch
More informationSurveillance of Fetal Alcohol Syndrome. Why Healthy People gave up counting
Surveillance of Fetal Alcohol Syndrome Why Healthy People gave up counting Healthy People Healthy People 2000 objective was to reduce the occurrence of FAS to 1.2 per 10,000 (0.12 per 1,000) Healthy People
More informationESP 755A SUMMER Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Autosomal recessive disorders
ESP 755A SUMMER 2017 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Autosomal recessive disorders a. affect only males c. are caused when the abnormal
More informationIdentification of Birth Defects in Michigan Infants with Sickle Cell Disease and Sickle Cell Trait: MI NBS and MBDR Data,
Identification of Birth Defects in Michigan Infants with Sickle Cell Disease and Sickle Cell Trait: MI NBS and MBDR Data, 2004-2006 Bethany Reimink, MPH Birth Defects/EHDI Epidemiologist Division of Genomics,
More informationINDIVIDUALS WITH AUTISM HAVE UNusual
ORIGINAL CONTRIBUTION Prevalence of Autism in a US Metropolitan Area Marshalyn Yeargin-Allsopp, MD Catherine Rice, PhD Tanya Karapurkar, MPH Nancy Doernberg Coleen Boyle, PhD Catherine Murphy, MPH For
More informationUNIVERSITY OF WASHINGTON
UNIVERSITY OF WASHINGTON THE FETAL ALCOHOL SYNDROME DIAGNOSTIC AND PREVENTION NETWORK (FAS DPN) Center for Human Development and Disability Dear Sir or Madam, Thank you very much for your request for an
More informationThe data were analysed using Fisher s exact test and the chi-squared test.
Congenital malformations are a major cause of perinatal and neonatal death [1], both in developed and developing countries [2]. These malformations have multifactorial etiologies and 40% of cases are idiopathic
More informationTHE NEW JERSEY AUTISM REGISTRY. NJ Department Of Health, Special Child Health Services, Early Identification & Monitoring Program
THE NEW JERSEY AUTISM REGISTRY NJ Department Of Health, Special Child Health Services, Early Identification & Monitoring Program Autism Brick Township, New Jersey, Autism cluster 6.7 per 1000 children
More informationHow Many Children have an Autism Spectrum Disorder?
How Many Children have an Autism Spectrum Disorder? Cathy Rice, Ph.D. National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention The findings and conclusions
More informationCancer Risk in Children with Birth Defects: A Population-Based Registry Linkage Study
Cancer Risk in Children with Birth Defects: A Population-Based Registry Linkage Study Philip J. Lupo, PhD Assistant Professor Birth Defects Nuremberg Chronicle, 1493 Page 1 xxx00.#####.ppt 11/23/2015 4:31:12
More informationTB/HIV/STD Epidemiology and Surveillance Branch. First Annual Report, Dated 12/31/2009
TB/HIV/STD Epidemiology and Surveillance Branch First Annual Report, Dated 12/31/29 This Enhanced Perinatal Surveillance Report is the first annual report generated by the Texas Department of State Health
More informationCOSTS OF HEALTH SERVICES UTILIZATION OF PEOPLE WITH FETAL ALCOHOL SPECTRUM DISORDER BY SEX AND AGE GROUP IN ALBERTA, CANADA
COSTS OF HEALTH SERVICES UTILIZATION OF PEOPLE WITH FETAL ALCOHOL SPECTRUM DISORDER BY SEX AND AGE GROUP IN ALBERTA, CANADA Nguyen Xuan Thanh 1,2, Egon Jonsson 1,2,3 1 Institute of Health Economics, Edmonton,
More informationReproductive Roulette
Slide title Reproductive Roulette Declining Reproductive Health, Dangerous Chemicals, and a New Way Forward By Reece Rushing July 2009 I Center for American Progress Reproductive Roulette Part I: Declining
More informationMalignancy ; 191.6; Malignant neoplasm of brain
APPENDIX 15 Comparison of ICD-9 Diagnostic Codes Used to Identify Children with Life-Threatening or Life-Limiting or Comple Chronic Conditions By Five CHI PACC Programs ICD-9 Category ICD-9 Description
More informationLow birthweight and respiratory disease in adulthood: A population-based casecontrol
Page 26 of 36 Online Data Supplement Low birthweight and respiratory disease in adulthood: A population-based casecontrol study Eric C. Walter, MD; William J. Ehlenbach, MD; David L. Hotchkin, MD, Jason
More informationNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States
More informationBabies First and CaCoon Risk Factors (A Codes and B Codes)
Babies First and Risk Factors (A Codes and B Codes) (Birth through 4 years of age) Medical Risk Factors A1. Drug exposed infant (See A29) A2. Infant HIV positive A3. Maternal PKU or HIV positive A4. Intracranial
More informationSurveillance Summaries. February 9, 2007 / 56(SS01);1-11
1 of 17 2/3/2012 9:17 PM Surveillance Summaries February 9, 2007 / 56(SS01);1-11 Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators Corresponding author:
More informationAutism Activities at CDC: The Public Health Model
Autism Activities at CDC: The Public Health Model Act Early Region II Summit Bronx, NY March 26, 2009 Marshalyn Yeargin-Allsopp, MD Georgina Peacock, MD, MPH National Center on Birth Defects and Developmental
More informationWashington, DC Washington, DC Services, Education, and Related Agencies Services, Education, and Related Agencies
June 12, 2018 The Honorable Roy Blunt The Honorable Tom Cole Chair Chair Subcommittee on Labor, Health and Human Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Services,
More informationEnvironmental Epidemiology: Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE)
Environmental Epidemiology: Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) Autism and the Environment: Challenges and Opportunities for Research A Workshop April 18-19,
More informationNon-covered ICD-10-CM Codes for All Lab NCDs
Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,
More informationPrevalence of Autism Spectrum Disorders Autism and Developmental Disabilities Monitoring Network, United States, 2006
Morbidity and Mortality Weekly Report www.cdc.gov/mmwr Surveillance Summaries December 18, 2009 / Vol. 58 / No. SS-10 Prevalence of Autism Spectrum Disorders Autism and Developmental Disabilities Monitoring
More informationCook County Department of Public Health. Maternal Child Health
Maternal Child Health Community Health Status Report 2010 Birth Rate What is it? The crude birth rate is the number of live births for a specified geographic area divided by the total population for that
More informationAutism spectrum disorders in young children: effect of changes in diagnostic practices
Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 9; all rights reserved. Advance Access publication 7 September 9 International Journal of Epidemiology
More informationThe Health of Children and Young People with Chronic Conditions and Disabilities in the Hutt Valley and Capital & Coast DHBs
The Health of Children and Young People with Chronic Conditions and Disabilities in the Hutt Valley and Capital & Coast DHBs This Report was prepared for the Hutt Valley and Capital & Coast DHBs by Elizabeth
More informationPopulation approaches to the primary prevention of birth defects. Carol Bower RACP Conference Adelaide 2016
Population approaches to the primary prevention of birth defects Carol Bower RACP Conference Adelaide 2016 Acknowledgements Research collaborators Consumer and community advisors and representatives Stakeholders
More informationMarijuana Use During Pregnancy and Breastfeeding Findings Summary
The Colorado Department of Public Health and Environment (CDPHE) was assigned the responsibility to appoint a panel of health care professionals with expertise in cannabinoid physiology to monitor the
More informationOriginal Contribution. Are Children With Birth Defects at Higher Risk of Childhood Cancers?
American Journal of Epidemiology ª The Author 2012. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail:
More informationDOI: /peds
Prevalence of Cerebral Palsy in 8-Year-Old Children in Three Areas of the United States in 2002: A Multisite Collaboration Marshalyn Yeargin-Allsopp, Kim Van Naarden Braun, Nancy S. Doernberg, Ruth E.
More informationProtecting Infants and Children from Pertussis and Influenza
September 23, 2016 Paulomi Shah, DO, FAAP Pediatrician, Medical Director Children s Medical Services, Sonoma County Alan Shotkin, MD, FAAP Neonatologist, Medical Director Santa Rosa Memorial Hospital Protecting
More informationSyndromes Associated with Congenital Heart Defects Moderator: Zenaida Steinhauer, New Jersey Department of Health & Senior Services, Trenton, NJ
Syndromes Associated with Congenital Heart Defects Moderator: Zenaida Steinhauer, New Jersey Department of Health & Senior Services, Trenton, NJ Angela E. Lin, Massachusetts General Hospital, Boston, MA
More informationCalifornia County Asthma Mortality Chart Book
California County Asthma Mortality Chart Book Data for 1990-1997 Gray Davis, Governor State of California Grantland Johnson, Secretary Health and Human Services Agency Diana M. Bontá, R.N., Dr.P.H., Director
More informationMedical Conditions Resulting in High Probability of Developmental Delay and DSCC Screening Information
Jame5. L.Jma5, ~reuiry Medical Conditions Medical Conditions Resulting in High Probability of Developmental Delay and DSCC Screening Information I Not Listed later Children with medical conditions which
More informationMississippi State Department of Health, Health Services / Office of Health Data and Research
Maternal and Child Health Mississippi State Department of Health, Health Services / Office of Health Data and Research Jackson, Mississippi Assignment Description The Mississippi State Department of Health
More informationIntroduction. Laura A. Schieve 1 Christine Fountain. Dmitry M. Kissin 3 Denise J. Jamieson
J Autism Dev Disord (2015) 45:2991 3003 DOI 10.1007/s10803-015-2462-1 ORIGINAL PAPER Does Autism Diagnosis Age or Symptom Severity Differ Among Children According to Whether Assisted Reproductive Technology
More informationChronic Liver Disease and Cirrhosis Deaths
Center for Health Statistics November 2003 DATA SUMMARY No. DS03-11001 This Data Summary is one of a series of leading cause of death reports. Chronic Liver Disease and Cirrhosis Deaths in California,
More informationSociety for Assisted Reproductive Technology and American Society for Reproductive Medicine
FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ASRM/SART REGISTRY
More informationSurveillance Summaries / Vol. 63 / No. 2 March 28, 2014
Morbidity and Mortality Weekly Report Surveillance Summaries / Vol. 63 / No. 2 March 28, 2014 Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years Autism and Developmental Disabilities Monitoring
More informationCorrelation of Neurodevelopmental Outcome and brain MRI/EEG findings in term HIE infants
Correlation of Neurodevelopmental Outcome and brain MRI/EEG findings in term HIE infants Ajou University School of Medicine Department of Pediatrics Moon Sung Park M.D. Hee Cheol Jo, M.D., Jang Hoon Lee,
More informationMonitoring Weight Status among Women of Reproductive Age. Renato Littaua, DVM, MPVM Healthy Weight and Pregnancy Webinar January 31, 2012.
1/31/12 Monitoring Weight Status among Women of Reproductive Age Renato Littaua, DVM, MPVM Healthy Weight and Pregnancy Webinar January 31, 12 Outline Methods Review overweight and obesity among non-pregnant
More informationAlcohol Consumption by Women Before and During Pregnancy
Matern Child Health J (2009) 13:274 285 DOI 10.1007/s10995-008-0328-2 Alcohol Consumption by Women Before and During Pregnancy Mary K. Ethen Æ Tunu A. Ramadhani Æ Angela E. Scheuerle Æ Mark A. Canfield
More informationFetal Growth Among Infants With Congenital Heart Defects by Maternal Race/Ethnicity
BRIEF COMMUNICATION Fetal Growth Among Infants With Congenital Heart Defects by Maternal Race/Ethnicity WENDY N. NEMBHARD, PHD, AND MELISSA L. LOSCALZO, MD PURPOSE: Congenital heart defects (CHDs) are
More informationPractice Problems--Midterm
Practice Problems--Midterm The following problems are similar to those that will appear on your midterm examination. The answers to the problems are given at the end of this lesson Use the following information
More informationChronic Liver Disease and Cirrhosis Deaths
Center for Health Statistics H i g h l i g h t s April 2004 DATA SUMMARY No. DS04-04000 This Data Summary is one of a series of leading cause of death reports. The chronic liver disease and cirrhosis crude
More informationFirst Interim Report to the European Commission DG-SANCO for: Grant Agreement No.: (790655) EAIS. December Annex 2
First Interim Report to the European Commission DG-SANCO for: Grant Agreement.:2005112 (790655) EAIS. December 2006 Annex 2 European Autism Information System (EAIS) Project: Design of a Prevalence study.
More informationInformation on the risks of Valproate (Epilim) use in girls (of any age), women of childbearing potential and pregnant women.
CONTAINS NEW INFORMATION GUIDE FOR HEALTHCARE PROFESSIONALS Information on the risks of Valproate (Epilim) use in girls (of any age), women of childbearing potential and pregnant women. Read this booklet
More informationWHAT IS AUTISM? Chapter One
WHAT IS AUTISM? Chapter One Autism is a life-long developmental disability that prevents people from understanding what they see, hear, and otherwise sense. This results in severe problems with social
More informationNational Children s Study Queens Vanguard Center
National Children s Study Queens Vanguard Center Philip J. Landrigan, MD, MSc, Principal Investigator Leo Trasande, MD, MPP, Queens and Nassau Location Principal Investigator Queens Vanguard Center A Consortium
More informationOklahoma Psychological Association DSM-5 Panel November 8-9, 2013 Jennifer L. Morris, Ph.D.
Oklahoma Psychological Association DSM-5 Panel November 8-9, 2013 Jennifer L. Morris, Ph.D. DSM-5 continues developmental progression, starting with disorders that are observed in early life. Disorders
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationPrevalence and characteristics of autistic spectrum disorders in the ALSPAC cohort
Prevalence and characteristics of autistic spectrum disorders in the ALSPAC cohort Emma Williams MSc PhD, Centre for Child and Adolescent Health; Kate Thomas MSc, Avon Longitudinal Study of Parents and
More informationPrevalence Estimates of Autism and Autism Spectrum Disorder in Massachusetts. Final Report December 2005
Prevalence Estimates of Autism and Autism Spectrum Disorder in Massachusetts Final Report December 2005 Prepared by: Center for Environmental Health Environmental Epidemiology Program Massachusetts Department
More informationHow common are the "common" neurologic disorders?
^ZH LIGHT How common are the "common" neurologic disorders? D. Hirtz, MD; D.J. Thurman, MD, MPH; K. Gwinn-Hardy, MD; M. Mohamed, MPH; A.R. Chaudhuri, PhD; and R. Zalutsky, PhD Review Article Abstract Objective:
More informationSmoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018
Smoking Cessation in Pregnancy Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Tobacco Cessation in Pregnancy: Objective 1. Overview of the negative effects of tobacco abuse in
More informationDo Multivitamin Supplements Attenuate the Risk for Diabetes-Associated Birth Defects?
Do Multivitamin Supplements Attenuate the Risk for Diabetes-Associated Birth Defects? Adolfo Correa, MD, PhD; Lorenzo Botto, MD; Yecai Liu, MS; Joseph Mulinare, MD, MSPH; and J. David Erickson, DDS, PhD
More informationTABLE I-1: RESIDENT INFANT DEATHS PER 1,000 LIVE BIRTHS, BY RACE AND ETHNICITY, FLORIDA AND UNITED STATES, CENSUS YEARS AND
TABLE I-1: RESIDENT INFANT DEATHS PER 1,000 LIVE BIRTHS, BY RACE AND ETHNICITY, FLORIDA AND UNITED STATES, CENSUS YEARS 1970-2000 AND 2004-2014 FLORIDA 1 UNITED STATES 1 YEAR WHITE2 BLACK2 HISPANIC3 WHITE2
More informationEpidemiologic Features and Clinical Subgroups of Anotia/Microtia in Texas
Ó 2009 Wiley-Liss, Inc. Epidemiologic Features and Clinical Subgroups of Anotia/Microtia in Texas Mark A. Canfield, 1 * Peter H. Langlois, 1 Ly M. Nguyen, 2 and Angela E. Scheuerle 1,3 1 Texas Birth Defects
More informationAnnex III. Amendments to relevant sections of the summary of product characteristics and package leaflets
Annex III Amendments to relevant sections of the summary of product characteristics and package leaflets Note: These amendments to the relevant sections of the Summary of Product Characteristics and package
More informationCDC s Public Health Research on Autism
CDC s Public Health Research on Autism José F. Cordero, MD, MPH Assistant Surgeon General Director, NCBDDD Centers for Disease Control and Prevention National Center on Birth Defects and Developmental
More informationPossible Precautions or Contraindications. Physical/Sexual/Emotional Abuse. Exacerbations of medical conditions
Dear Physician, Your patient,, DOB: is interested in participating in one of the following: Physical and/or Occupational Therapy evaluation and treatment using all appropriate treatment methods including
More informationMEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS
MEDICAL POLICY PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationTable of Contents. 2 P age. Susan G. Komen
CALIFORNIA Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 5 Quantitative Data: Measuring Breast
More informationAFL NSW/ACT Exemption & Dispensation Policy
AFL NSW/ACT Exemption & Dispensation Policy Last reviewed 14 May 2012. AFL NSW/ACT s policy is that age exceptions and/or dispensations will only exist in cases of disability These exemptions require approval
More informationTo measure concentrations of mercury in blood, urine and stools of infants who. that received thimerosalcontaining
Recent Scientific Studies on Thimerosal and Autism Publication Study Lead Researcher Objective Method/Design Conclusion* Funding The Lancet November 2002 Institutes of Mercury concentrations and metabolism
More informationMethods PEDIATRIC CARDIOLOGY
1805 PEDIATRIC CARDIOLOGY Trends and Outcomes After Prenatal Diagnosis of Congenital Cardiac Malformations by Fetal Echocardiography in a Well Defined Birth Population, Atlanta, Georgia, 1990 1994 EDUARDO
More informationInternational Registries: The Government-Driven Model
International Registries: The Government-Driven Model Pål Surén Norwegian Institute of Public Health Presentation outline Overview of Norwegian health registries The Norwegian Mother and Child Cohort Study
More informationMatching enhances IIS data assessing Tdap and influenza vaccine uptake during pregnancy in Washington State
Matching enhances IIS data assessing Tdap and influenza vaccine uptake during pregnancy in Washington State Joanna Eavey, MSPH - joanna.eavey@doh.wa.gov AIRA IIS National Meeting April 5 7, 2016 Background
More informationNon-covered ICD-10-CM Codes for All Lab NCDs
Non-covered ICD-10-CM Codes for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the
More informationNew Patient Information Form
New Patient Information Form Patient Identification Prenatal Alcohol & Drug Exposure Clinic FASD CLINIC Patient s OHIP N. Female Male Race Patient s Name Birth Date Age First Middle Last Patient s Address
More informationIntroduction. Background
Introduction The Orange County Substance Exposed Babies Report, 2007 1, on substance use by pregnant women in Orange County found that 15% of all babies were exposed to alcohol, tobacco, and/or other drugs
More information47361 Developmental Psychopathology University of Massachuestts Lowell Dr. Doreen Arcus
Mental Retardation Mash & Wolfe Powerpoint Historical Perspectives on Mental Retardation Historically, prevailing sentiment was ignorance and mistreatment Degeneracy theory (1800 s) saw MR as regression
More informationNon-covered ICD-10-CM Codes for All Lab NCDs
Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,
More informationBORN. The power of database linkage: a new source of longitudinal maternal-child data is
The power of database linkage: a new source of longitudinal maternal-child data is BORN Deshayne Fell, Steven Hawken, Robin Ducharme, Ann Sprague, Kumanan Wilson, Astrid Guttmann, Nelson Chong, Mark Walker
More informationAPPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME
APPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME Table 1. List of European registries contributing to the study: years of data, total number of births, prenatal diagnosis policy, followup of cases
More informationBrant County Community Health Status Report: 2001 OVERVIEW
Brant County Community Health Status Report: 2001 OVERVIEW Brantford County of Brant Brant County Health Unit and Grand River District Health Council April 2001 Brant County Community Health Status Report:
More informationPrevalence of Autism Spectrum Disorders Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008
/ Vol. 61 / No. 3 Morbidity and Mortality Weekly Report March 30, 2012 Prevalence of Autism Spectrum Disorders Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008 U.S.
More informationPrevalence of Autism Spectrum Disorders Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008
Morbidity and Mortality Weekly Report Surveillance Summaries / Vol. 61 / No. 3 March 30, 2012 Prevalence of Autism Spectrum Disorders Autism and Developmental Disabilities Monitoring Network, 14 Sites,
More informationIsle of Wight Joint Strategic Needs Assessment: Core Dataset 2009
Isle of Wight Joint Strategic Needs Assessment: Core Dataset 2009 Domain: Burden of Ill Health Indicator: Hospital Admissions - Top 10 Causes Sub-Domain: Misc Indicator References: JSNA Core Dataset number
More informationHistorical Perspectives on the Etiology of Cerebral Palsy 233 Tonse N.K. Raju
PERINATAL CAUSES OF CEREBRAL PALSY Preface Marcus C. Hermansen xv Historical Perspectives on the Etiology of Cerebral Palsy 233 Tonse N.K. Raju This essay presents the early history on the evolution of
More informationThis is a pre-publication version of the article published in the Journal of Clinical Practice in Speech Language Pathology
CHANGING THE WAY WE DIAGNOSE AUTISM 1 This is a pre-publication version of the article published in the Journal of Clinical Practice in Speech Language Pathology Changing the way we diagnose autism: Implications
More informationDisclosures. Win Fertility UpToDate
Disclosures Win Fertility UpToDate Excess preterm birth Low birth weight Small for gestational age infants Neonatal death But prior studies limited by: Lack of statistical power Inaccurate vital records
More informationChanges in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U.S. Children: 2007 to
Number 65 n March 20, 2013 Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U.S. Children: 2007 to 2011 2012 by Stephen J. Blumberg, Ph.D., Matthew D. Bramlett, Ph.D., National
More information/RFDO )LQGLQJV. Cancers All Types. Cancer is the second leading cause of death in Contra Costa.
Cancers All Types Cancer is the second leading cause of death in Contra Costa. Deaths Contra Costa s cancer death rate (170.5 per 100,000) does not meet the national Healthy People 2010 objective (159.9
More informationGSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Data Source:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationMICROCEPHALY DEVELOPMENTAL IMPLICATIONS IN BIRTH-3 Diana M. Cejas, MD, MPH Child Neurology Fellow The University of Chicago Comer Children s Hospital
Early Intervention Training Program at the University of Illinois at Urbana Champaign presents Microcephaly: Developmental Implications in Birth-3 The webinar will begin at (1:30 PM CST). There will be
More information